Vulvar carcinoma is a cancer that starts in the outer tissues of the female genitals, most often in older adults but sometimes in younger people too. Early symptoms of vulvar carcinoma can include ongoing itching, pain, burning, bleeding, or a lump or sore that does not heal. Vulvar carcinoma may develop slowly over months or years, and some people notice skin color changes before a cancer is found. Not everyone will have the same experience, but vulvar carcinoma can be serious and may be life-threatening if it spreads. Treatment often includes surgery, and some people also need radiation therapy, chemotherapy, or other medicines.
How many people live with Vulvar carcinoma?
Looking at people who had been diagnosed within the past 5 years, about 170,000 were living with vulvar cancer worldwide in 2022 (Global Cancer Observatory, 2022). In the United States, the estimate was about 27,000 people (Global Cancer Observatory, 2022).
Overview
Vulvar carcinomaSymptoms
Vulvar carcinoma often causes a lump, sore, or patch on the vulva that does not heal. Many notice itching, pain, burning, bleeding, or skin color changes; early symptoms of vulvar carcinoma can be easy to miss.
Outlook and prognosis
The outlook for vulvar carcinoma is often good when it is found early and treated promptly. Smaller cancers confined to the vulva usually have better results, while spread to nearby lymph nodes or other areas can make treatment more challenging.
Causes and risk factors
Vulvar carcinoma risk rises with HPV infection, smoking, older age, and long-term skin conditions such as lichen sclerosus. Weakened immunity also increases risk. Some cases relate to inherited cancer risk, but most do not.
Genetic influences
Genetics usually play a smaller role in vulvar carcinoma than in some other cancers. Most cases are linked more to acquired DNA changes over time, though rare inherited cancer syndromes and certain genetic variations can modestly raise vulvar carcinoma risk.
Diagnosis
Vulvar carcinoma is usually diagnosed with a pelvic exam and a close look at any sore, lump, or skin change. The diagnosis of vulvar carcinoma is confirmed with a biopsy. Imaging may be used to check spread.
Treatment and drugs
Treatment for vulvar carcinoma often includes surgery to remove the cancer, sometimes with nearby lymph nodes. Some people also need radiation, chemotherapy, or both. Care also focuses on pain relief, wound healing, sexual comfort, and regular follow-up.
Symptoms
Changes in the skin of the vulva can be easy to miss at first, especially if they come and go. With vulvar carcinoma, symptoms often begin in one area and may slowly become more persistent. You might notice small changes at first, such as itching, soreness, or a spot that does not heal.
Persistent itching is one of the early symptoms of vulvar carcinoma, although many noncancerous skin problems can cause it too. The itch may keep coming back or last for weeks, and scratching can make the area feel raw or burn.
The skin may look thicker, rougher, lighter, darker, or more red than the surrounding area. With vulvar carcinoma, these changes often stay in one spot instead of clearing up.
Some people notice a small bump, wart-like growth, or open sore on the vulva. A spot that bleeds easily or does not heal should be checked.
The area can feel sore, tender, or irritated, especially with walking, sitting, or tight clothing. Some may find that the discomfort becomes more noticeable during exercise or after a long day.
How people usually first notice Vulvar carcinoma?
Vulvar carcinoma is often first noticed as a change that does not go away, such as persistent itching, burning, pain, or a lump, sore, or patch of skin on the vulva that looks different from the surrounding area. Many people living with vulvar carcinoma first see color or texture changes, including skin that becomes thicker, lighter, darker, redder, or rougher, and some notice bleeding, discharge, or an open area that does not heal. These symptoms can also happen with much more common, noncancerous conditions, but if a vulvar symptom lasts for weeks or keeps coming back, it is a good reason to get checked.
Types of Vulvar carcinoma
Vulvar carcinoma can show up in a few different forms, and the type often affects how it looks and feels day to day. Some growths cause itching or a sore that does not heal, while others look more like a dark spot, a lump, or an area of thickened skin. Symptoms don’t always look the same for everyone. When doctors talk about the types of vulvar carcinoma, they usually mean the kind of cells the cancer started from.
Squamous cell
This is the most common type of vulvar carcinoma, and it often starts in the thin skin covering the vulva. Many living with this type notice itching, burning, pain, bleeding, or a sore, patch, or lump that does not go away.
Vulvar melanoma
This type starts in pigment-making cells and often appears as a dark brown, black, or unevenly colored spot. Some may also notice itching, bleeding, or a mole-like area that changes in size, shape, or color.
Adenocarcinoma
This less common type starts in gland tissue, including Bartholin gland tissue in some cases. It may feel more like a deeper lump, swelling, or tenderness near the vaginal opening rather than a surface skin patch.
Verrucous carcinoma
This is a rare, slow-growing form of squamous cell cancer that often looks like a large wart-like growth. It may cause irritation, discharge, or discomfort from rubbing, but it sometimes grows for a while before becoming painful.
Basal cell
This rare type often develops as a small bump or sore on the vulva, sometimes with crusting or an area that keeps breaking down and healing. It tends to grow slowly, so early symptoms of vulvar carcinoma in this form can be subtle at first.
Can I slow down the onset of symptoms?
Not really in the sense of delaying symptoms: there is no proven lifestyle change that can reliably slow symptom onset once vulvar cancer has started, but some steps can lower the chance of developing this cancer in the first place. The clearest ones are getting the HPV vaccine if it is appropriate for you, not smoking, and getting ongoing vulvar itching, burning, sores, skin color changes, or thickened skin checked early, because treating certain long-term skin problems or precancerous changes can reduce risk. Regular gynecology visits and a prompt biopsy of any suspicious area are well-established ways to find problems early, and while these steps cannot guarantee prevention, they can still make a real difference.
What genetics can tell you about symptoms
For vulvar carcinoma, genetics usually cannot tell exactly which symptoms someone will have day to day, because symptoms such as itching, pain, burning, bleeding, or a sore that does not heal are driven more by where the cancer is, how large it is, and how far it has spread. Genetic changes in the tumor can still matter: they can help show which type of vulvar cancer is present and whether it may have developed slowly over time or be more aggressive, which can influence when symptoms begin and sometimes how severe they become. In some people, an HPV-related cancer and a cancer linked to other gene changes follow different patterns, but genetics is only one part of the picture.
Causes and risk factors
Vulvar carcinoma can develop when cells in the vulva are damaged over time. Common risk factors for vulvar carcinoma include long-lasting infection with certain types of HPV, older age, smoking, and a weakened immune system. Ongoing skin conditions of the vulva, especially lichen sclerosus, can also raise risk. Family history can be one part of the story, but lifestyle and environment add their own chapters. Rare inherited gene changes may play a part, but they are not a common cause.
What are the most common causes or risk factors?
There is not usually one single cause of vulvar carcinoma, but the strongest risk factors are long-term infection with human papillomavirus, or HPV, a common virus spread through sexual contact, and a long-lasting skin condition of the vulva that can cause itching, thinning, and scarring. The risk also goes up with older age, smoking, a weakened immune system, and a history of precancer or cancer in the cervix, vagina, or vulva. Inherited genes do not seem to be a major cause for most people, so this cancer is usually not strongly passed down in families.
Environmental and biological risk factors
Understanding the main risk factors for vulvar carcinoma can make the condition feel less unpredictable. Doctors often group risks into internal (biological) and external (environmental). The biggest known risks include older age, persistent human papillomavirus infection, certain long-term vulvar skin conditions, and a weakened immune system.
Vulvar carcinoma becomes more common with increasing age, especially after menopause. This is likely because cell damage and long-standing skin changes can build up over many years.
Long-lasting infection with high-risk human papillomavirus, or HPV, can raise the chance of vulvar carcinoma. In some people, the virus causes cell changes that do not clear as they should.
People who have vulvar precancer, sometimes called VIN, have a higher risk of vulvar carcinoma. The risk is greater when abnormal cells persist, recur, or involve larger areas.
This long-term vulvar skin condition can cause itching, fragile skin, and ongoing inflammation. Over time, some people with lichen sclerosus develop abnormal cell changes that raise cancer risk.
Genetic risk factors
Most people with vulvar carcinoma do not have a strong inherited genetic cause. More often, the disease develops after DNA changes build up in vulvar cells during life, rather than from a gene change passed down through a family. Carrying a genetic change doesn’t guarantee the condition will appear. When people ask about genetic risk factors for vulvar carcinoma, the key point is that inherited risk seems uncommon, while tumor gene changes are more often involved.
Acquired mutations: Most vulvar carcinomas are linked to DNA changes that happen in the vulvar tissue itself after birth. These changes can push cells to grow in abnormal ways, but they usually are not passed from parent to child.
TP53 changes: Some vulvar carcinomas have changes in TP53, a gene that helps damaged cells stop growing or die off. When this safeguard fails, abnormal cells can survive longer and keep dividing.
Cell-cycle genes: Changes in genes such as CDKN2A can weaken the normal brakes that control how fast cells move through the growth cycle. That loss of control may make it easier for a cancer to develop.
Growth pathway genes: Some tumors carry changes in genes such as PIK3CA, PTEN, or HRAS, which are involved in cell growth signals. If these signals stay switched on, cells may multiply more than they should.
Rare inherited syndromes: A small number of people may have inherited conditions that affect DNA repair and increase the risk of several cancers, including vulvar carcinoma. These syndromes are rare and do not explain most cases.
Family history: Having relatives with vulvar carcinoma does not usually point to a strong inherited pattern on its own. Still, if several close family members have related cancers, a doctor or genetic counselor may consider whether genetic testing would be helpful.
Lifestyle risk factors
Several everyday habits can influence the chance of developing vulvar carcinoma, although some have much stronger evidence than others. When people ask about lifestyle risk factors for vulvar carcinoma, smoking and behaviors that increase long-term HPV exposure are the clearest modifiable factors. Excess body weight and low physical activity may also contribute indirectly, but their role appears less consistent.
Cigarette smoking increases the risk of vulvar carcinoma, especially HPV-related disease. It can weaken local immune defenses and make it harder for the body to clear HPV infection.
Having multiple sexual partners or sex without barrier protection can increase exposure to high-risk HPV, a major driver of many vulvar cancers. Earlier sexual debut can also raise the chance of persistent HPV infection over time.
Lifestyle patterns that increase the chance of repeated or untreated HPV infection can raise vulvar carcinoma risk. Not keeping up with sexual health care after abnormal HPV-related results may allow precancerous changes to progress.
Obesity has been linked to a higher risk of several gynecologic cancers and may also contribute to vulvar carcinoma in some people. Chronic inflammation and metabolic changes are possible reasons for this association.
Risk prevention
Vulvar carcinoma cannot always be prevented, but some steps can lower the risk or help doctors find changes early, when treatment is often simpler. Risk is often linked to long-term infection with certain types of human papillomavirus, smoking, chronic skin irritation, and older age, although not everyone with these risks develops cancer. Prevention is about lowering risk, not eliminating it completely. Paying attention to persistent itching, pain, skin color changes, or a sore that does not heal can also help with early symptoms of vulvar carcinoma.
Vaccination against HPV can lower the risk of the virus-related cell changes that sometimes lead to vulvar carcinoma. It works best before exposure to HPV, but some older teens and adults may still benefit depending on age and health history.
Using condoms and limiting exposure to sexually transmitted infections may reduce the chance of HPV infection, which is an important risk factor for some vulvar carcinoma cases. Condoms do not fully block HPV, but they can still help lower risk.
Smoking weakens the body's ability to clear HPV and raises the risk of several cancers, including vulvar carcinoma. If you smoke, quitting can lower future risk and support overall healing and immune health.
Pelvic and gynecologic exams can help spot vulvar skin changes before they become more serious or when vulvar carcinoma is still at an early stage. Prevention works best when combined with regular check-ups.
Can you prevent Vulvar carcinoma?
You cannot fully prevent vulvar cancer, but some cases may be lower risk. Getting the HPV vaccine, not smoking, and having long-lasting itching, pain, lumps, sores, or skin color changes around the vulva checked early can help, because some vulvar cancers begin as treatable early changes. Even with these steps, vulvar cancer can still happen, so regular women's health checkups and prompt attention to new symptoms are important.
Transmission
Vulvar carcinoma is not contagious, so it cannot be transferred from one person to another through sex, skin contact, kissing, shared toilets, towels, or everyday close contact. Many people ask whether vulvar carcinoma is contagious, and the answer is no.
Some cases are linked to a long-term infection with human papillomavirus, or HPV, which can spread through sexual contact, but the virus is what can be passed on, not the cancer itself. Other cases of vulvar carcinoma are related to factors such as age, smoking, immune system problems, or long-standing skin conditions rather than any form of infection.
When to test your genes
For vulvar carcinoma, genetic testing is not routinely used for early detection because most cases are not inherited. It may be worth discussing if you have a strong family history of breast, ovarian, uterine, or colon cancer, or if your cancer is advanced or returns, when tumor testing can sometimes guide treatment.
Diagnosis
Vulvar carcinoma is often suspected when ongoing itching, pain, burning, bleeding, or a new lump or sore on the vulva does not go away. You might notice small changes in daily routines, such as discomfort when sitting, walking, or using the bathroom, that lead to a medical visit. The diagnosis of vulvar carcinoma usually starts with an exam and is confirmed with a tissue sample.
A doctor asks about symptoms, how long they have been present, and whether there have been changes in skin color, sores, bleeding, or pain. They also ask about past skin conditions, HPV-related disease, smoking, and any earlier abnormal biopsy results.
The vulva is examined closely for patches, ulcers, raised areas, or lumps that look suspicious. The doctor may also examine the vagina, cervix, and nearby skin to check for other changes.
A small sample of tissue is removed from the abnormal area and sent to a lab for testing. This is the main way to confirm vulvar carcinoma and tell it apart from infections, inflammatory skin problems, or precancerous changes.
A pathologist studies the biopsy under a microscope to confirm whether cancer is present and what type it is. The report may also describe how deep the tumor grows, which helps guide treatment planning.
How is Vulvar carcinoma diagnosed?
Vulvar carcinoma, also called vulvar cancer, is usually diagnosed after a doctor asks about symptoms and closely examines the vulva, often looking at any sore, lump, skin thickening, color change, or area that does not heal. The key test is a biopsy, which means taking a very small sample of tissue and checking it under a microscope to see if cancer cells are present. If cancer is found, imaging tests and sometimes checks of small glands in the groin may be done to see whether it has spread, but genetic testing is not usually the main way this cancer is diagnosed.
Stages of Vulvar carcinoma
Vulvar carcinoma is usually described by stages based on how far the cancer has grown or spread, rather than by a day-to-day pattern of symptoms. In practice, the stages of vulvar carcinoma help doctors plan treatment and talk about what to expect. Doctors usually start with a conversation about symptoms, an exam, and a biopsy to confirm the diagnosis, then use scans or lymph node checks to see whether it has spread.
Stage 1
The cancer is only in the vulva or perineum, the area between the vaginal opening and anus. It has not spread to nearby lymph nodes or to other parts of the body. This is often the earliest stage, although early symptoms of vulvar carcinoma can still be easy to miss.
Stage 2
The cancer has grown into nearby structures such as the lower part of the vagina, the lower urethra where urine passes, or the anus. It still has not spread to nearby lymph nodes or distant organs. Treatment planning often focuses on the exact size and location of the tumor.
Stage 3
The cancer may still be centered in the vulva and nearby tissues, but it has spread to lymph nodes in the groin. Some lymph nodes may be larger or show signs that cancer has broken through the outer covering. This stage can raise the chance that treatment will include more than one approach.
Stage 4
The cancer has spread more widely, either into nearby pelvic structures such as the upper urethra, upper vagina, bladder, or rectum, or to distant parts of the body. This is the most advanced stage of vulvar carcinoma. Different tests may be suggested to help show exactly where the cancer is and guide treatment choices.
Outlook and prognosis
Outlook for vulvar carcinoma depends mainly on stage at diagnosis, lymph node involvement, tumor size, and whether the cancer can be completely removed. When found early and confined to the vulva, treatment is often highly effective, and many patients have a good long-term prognosis. Survival is lower when cancer has spread to the groin or pelvic lymph nodes, nearby organs, or distant sites, and recurrence can occur even after initial successful treatment, so close follow-up is important. Reported 5-year relative survival is generally around 80% to 90% for localized disease, about 50% to 60% for regional spread, and much lower, often under 25%, for distant metastatic disease. Mortality is therefore relatively low in early-stage cases but rises substantially with advanced stage, older age, and serious coexisting illnesses. Early evaluation of persistent vulvar itching, pain, bleeding, or a new lesion offers the best chance of cure and improved survival.
Long-term effects
Vulvar carcinoma can have lasting effects that come not only from the cancer itself, but also from surgery, radiation, and the emotional strain of treatment. For many, symptoms and day-to-day changes depend on how advanced the cancer was and which treatments were needed. Thinking about the long-term effects helps people prepare for changes in comfort, sexual health, mobility, and follow-up care.
Some people living with vulvar carcinoma have ongoing pain, burning, numbness, or tenderness in the vulvar area after treatment. Sitting for long periods, wearing tight clothing, or sexual contact may stay uncomfortable for months or longer.
Surgery and radiation can leave scar tissue that changes how the vulva looks and feels. For many, this can mean tightness, pulling, or reduced flexibility of the skin in everyday movement.
Long-term sexual problems are common after vulvar carcinoma treatment, especially if tissue has been removed or irradiated. Some may find vaginal dryness, pain with sex, lower desire, or worry about intimacy become lasting concerns.
Depending on the tumor site and treatment area, some people have lasting problems with urination or bowel function. This can include urgency, leakage, irritation, or discomfort, especially after radiation.
How is it to live with Vulvar carcinoma?
Living with vulvar carcinoma can affect some of the most private parts of daily life: walking, sitting, exercising, urinating, sexual intimacy, and even choosing clothing may become uncomfortable, especially during treatment. Many people also carry an emotional weight that others cannot see, including worry about body image, pain, recurrence, and the strain of repeated appointments, surgery, radiation, or recovery. For partners, family, and close friends, this can mean stepping into caregiving roles, adjusting routines, and learning how to offer support around very personal symptoms, but honest communication and good medical care often help people regain comfort, confidence, and a sense of control.
Treatment and drugs
Treatment for vulvar carcinoma depends on the size and location of the cancer, whether it has spread, and your overall health, but surgery is often the main treatment. In some cases, doctors also use radiation therapy, chemotherapy, or both, either to shrink the cancer before surgery or to lower the chance of it coming back afterward. For many people, treatment begins with small daily steps, such as wound care after surgery, managing discomfort, and keeping follow-up visits. If vulvar carcinoma is advanced or returns after treatment, care may include drug treatment to slow the cancer, ease symptoms, and support quality of life. Not every treatment works the same way for every person, so the best plan is usually made with a cancer specialist who can explain the benefits, side effects, and what recovery may look like day to day.
Can you cure Vulvar carcinoma?
Vulvar carcinoma, which is cancer of the vulva, can sometimes be cured, especially when it is found early and treated before it has spread. There is not one guaranteed cure for everyone, and if the cancer is more advanced, treatment may focus on removing or shrinking the cancer, easing symptoms, and lowering the chance that it comes back. Treatment often includes surgery, and some people also need radiation or medicine used to treat cancer.
Non-drug treatment
Treatment for vulvar carcinoma often centers on removing or targeting the cancer while protecting comfort, bladder and bowel function, and sexual health as much as possible. Managing this condition often involves a mix of local treatment, treatment to nearby lymph nodes, and supportive care based on the cancer’s size, location, and stage. For many, treatment options for vulvar carcinoma are planned by a team that may include a gynecologic cancer surgeon, radiation specialist, wound-care clinicians, and rehabilitation therapists. The best plan can look different from one person to another, especially if the cancer is very early, more advanced, or has come back after earlier treatment.
Surgery is the main non-drug treatment for many people with vulvar carcinoma. It aims to remove the cancer with a rim of healthy tissue while preserving as much normal tissue as safely possible. Depending on the size and site, this may range from a small local excision to a larger operation.
Nearby groin lymph nodes may need to be checked because vulvar carcinoma can spread there first. This is often done with sentinel node biopsy or removal of more lymph nodes when the risk is higher. The results help guide the rest of treatment.
Radiation uses high-energy beams to treat the tumor or areas at risk for spread. It may be used instead of surgery in some cases, before or after surgery, or when surgery would be too extensive. Skin soreness, fatigue, and irritation in the treated area can happen, so careful skin care matters.
Laser therapy is not a standard treatment for invasive vulvar carcinoma, but it may be used for certain precancerous changes on the vulva. It works by destroying abnormal surface tissue without a large incision. This approach is only suitable when testing shows there is no deeper invasive cancer.
Your genes may have an impact on how drugs work for you
For people with vulvar cancer, treatment is often centered on surgery and sometimes radiation, so gene-based drug matching is not yet a routine part of care the way it is for some other cancers. Even so, small inherited differences in how the body breaks down medicines can affect how some people respond to chemotherapy, pain medicine, or anti-nausea drugs, which may mean stronger side effects, less relief, or a need to adjust the dose. This area is called pharmacogenomics, meaning how genes can shape medicine response, but in vulvar cancer it is still used in a limited way and your care team usually bases treatment more on the stage of the cancer and your overall health.
Pharmacological treatments
Medicines are not the main treatment for many people with vulvar carcinoma, but they can play an important role when the cancer is advanced, has spread, has come back, or is being treated together with radiation. The drugs used most often are chemotherapy medicines such as cisplatin, carboplatin, paclitaxel, 5-fluorouracil, and mitomycin. Some people may also be offered immunotherapy, most commonly pembrolizumab, in certain advanced cases based on the tumor’s test results. Not everyone responds to the same medication in the same way.
Cisplatin is one of the most commonly used drugs for vulvar carcinoma, often given with radiation to help the treatment work better in the pelvis or groin. It may also be used in treatment for advanced vulvar carcinoma when the disease cannot be fully managed with surgery alone.
Carboplatin and paclitaxel are chemotherapy drugs often used together for vulvar carcinoma that has spread or returned after earlier treatment. This combination is usually given by vein in cycles and may help shrink tumors or slow their growth.
5-fluorouracil and mitomycin are older chemotherapy medicines that may be used with radiation in selected cases, especially when doctors want to strengthen local treatment. They are not right for everyone, but they remain established options in some treatment plans.
Pembrolizumab is an immunotherapy drug that helps the immune system recognize and attack cancer cells. It may be considered for some people with recurrent or metastatic vulvar carcinoma, especially if the tumor has certain markers such as PD-L1 positivity, MSI-H, or high tumor mutational burden.
Genetic influences
When someone is diagnosed with vulvar carcinoma, it is understandable to wonder whether it could be inherited. Most vulvar carcinoma is not strongly passed down through families and is more often linked to factors such as long-term human papillomavirus (HPV) infection, older age, smoking, or chronic vulvar skin disease. Genes can still play a part, though, because some people inherit a higher overall tendency toward certain cancers or toward body responses that make these other triggers more important. Family history is one of the strongest clues to a genetic influence, especially if several close relatives have had the same or related cancers. Most gene changes found in vulvar carcinoma happen in the tumor over time rather than being gene changes you were born with. For many living with this diagnosis, genetic risk factors for vulvar carcinoma are only one piece of the picture, and genetic counseling or testing is usually considered mainly when the personal or family history suggests a broader inherited cancer syndrome.
Is Vulvar carcinoma genetic?
Genetics usually play a smaller role in vulvar carcinoma than in some other cancers. Most cases are linked more to acquired DNA changes over time, though rare inherited cancer syndromes and certain genetic variations can modestly raise vulvar carcinoma risk.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most of these variants do not have a direct effect on health and are simply part of normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people with vulvar carcinoma, the biggest treatment questions are whether surgery will be enough or whether radiation or medicines will also be needed. Genetics can matter, but right now they usually guide care less than the cancer’s size, depth, spread to nearby lymph nodes, and whether it has come back. Genetics is only one factor, and in vulvar carcinoma there is not usually a standard inherited gene test that decides the main treatment the way it can in some other cancers. In advanced or recurrent cases, genetic testing for vulvar carcinoma may sometimes examine the tumor for changes or immune markers that could make certain newer drugs an option, although this is still a developing area and does not help in every case. Inherited genetic differences can also affect how your body breaks down some medicines, which may influence side effects or dosing, but this kind of pharmacogenetic testing is not yet a routine part of vulvar carcinoma care. If standard treatment has not worked or the cancer has returned, your care team may consider both the tumor’s genetic features and your overall health when reviewing the next treatment options.
Interactions with other conditions
People living with vulvar carcinoma may also be dealing with other health problems that affect symptoms, treatment choices, and recovery. Another important aspect is how it may link with other diseases. Long-term skin conditions of the vulva, especially lichen sclerosus, can raise the risk of vulvar carcinoma, and ongoing irritation or skin changes can make the early symptoms of vulvar carcinoma harder to spot. It can also occur alongside precancer or cancer in nearby areas, such as the cervix, vagina, or anus, especially when these conditions are related to human papillomavirus, often called HPV. For many, other illnesses such as diabetes, immune system problems, or smoking-related lung and heart disease can slow healing after surgery and increase the risk of infection or other complications. Depression, anxiety, and chronic pain may also become more significant during treatment, so it helps when cancer care is coordinated with the doctors managing these conditions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Vulvar carcinoma?
Other problems that can look or feel similar to vulvar cancer include yeast infections, eczema or other skin irritation, genital warts, and a blocked Bartholin gland, which can cause a tender lump near the vaginal opening. A long-lasting skin condition called lichen sclerosus, which makes the skin thin, pale, and very itchy, can also be mistaken for it and is important to rule out. Because these symptoms can overlap, ongoing itching, pain, bleeding, skin changes, or a new lump should be checked by a doctor.
History
Changes on the vulva can be easy to dismiss at first. What may seem like ongoing itching, a sore spot that does not heal, or pain when sitting or using the bathroom has likely affected women for a very long time, even before doctors had a clear name for it. Throughout history, people have described chronic vulvar irritation and visible growths, but for centuries these problems were often hidden because of shame, limited medical care, and the private nature of the symptoms.
As doctors began recording illnesses more systematically in the 1800s and early 1900s, unusual vulvar ulcers and tumors were described in medical texts and gradually separated from infections and other skin conditions. Early reports did not always distinguish vulvar carcinoma from other causes of vulvar disease, especially when diagnosis relied only on what could be seen or felt during an exam. Not every early description was complete, yet together they helped build today’s understanding that cancer of the vulva can develop in more than one way and may affect women at different ages.
During the 20th century, better microscopes and tissue testing made diagnosis much more accurate. This helped doctors recognize precancerous changes, understand that some cases are linked to long-standing skin disease while others are connected to certain viral infections, and see why early symptoms of vulvar carcinoma can be mistaken for more common problems such as eczema or irritation. In recent decades, awareness has grown as screening for related gynecologic conditions improved, surgery became more tailored, and researchers later identified genetic and cell-level changes involved in how some vulvar cancers develop.
The history of vulvar carcinoma is also a history of changing attitudes toward women’s health. In the past, many living with vulvar symptoms may have delayed care out of embarrassment or because they were told the problem was “just irritation.” Today, the condition is better recognized, diagnosis is more precise, and treatment is often planned with more attention to both cancer control and quality of life. Looking back helps explain why persistent vulvar itching, pain, skin color change, or a sore that does not heal should be taken seriously and checked promptly.